Delivery Order SPE2DB22D1106-SPE2DB25FFFB2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes, with a contract ceiling value of $3,323.09. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, under a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for OVIDREL 250 MCG/0.5 ML syringes valued at $1,259.20 with a firm fixed price structure. The award, issued on July 26, 2025, is a non-set-aside competitive contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office operations serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,765.72 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes with a completion date of September 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing for the pharmaceutical product delivery, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ovidrel 250 mcg/0.5 mL syringes, with a ceiling value of $4,201.80. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, awarded on August 11, 2025. This award carries no set-aside designation and represents a competitively awarded transaction. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $4,305.13 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes. The award, issued on May 22, 2025, with an ultimate completion date of May 23, 2025, represents a firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $4,757.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 250 mcg/0.5 ml OVIDREL syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The Defense Logistics Agency awarded a $226,980 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OVIDREL 250 MCG/0.5 ML prefilled syringes. The single day contract has a period of performance from August 17 to August 18, 2023. Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply needs. No set aside provisions or subcontractors were identified for this...
- The Defense Logistics Agency Troop Support Medical awarded a $169.77 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified pharmaceutical product from its place of performance in Conshohocken, Pennsylvania between September 8-11, 2023. The delivery order was issued against the Defense Logistics Agency's prime vendor contract vehicle for medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) Troop Support Medical with pharmaceutical products and medical supplies, primarily in the form of firm fixed price delivery orders. The award, valued at up to $3,964.50, is for the procurement of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical. The contract has an ultimate completion date of March 22, 2024 and was awarded on March...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $3,585.48 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFB2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,222.90 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ovidrel 250 mcg/0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a single-line delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor to the Defense Logistics Agency's medical supply chain, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical commodities to support military and federal healthcare systems globally. The company's federal contract history demonstrates consistent capability to fulfill competitive procurements across multiple therapeutic domains, ranging from specialty medications to vaccines and medical devices, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/25/25 |